"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".
about
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and Without Cocaine Dependence.Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.Structurally-Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice.
P2860
"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats".
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
"Effects of the novel relative ...... self-administration in rats".
@en
"Effects of the novel relative ...... self-administration in rats".
@nl
type
label
"Effects of the novel relative ...... self-administration in rats".
@en
"Effects of the novel relative ...... self-administration in rats".
@nl
prefLabel
"Effects of the novel relative ...... self-administration in rats".
@en
"Effects of the novel relative ...... self-administration in rats".
@nl
P2860
P1433
P1476
"Effects of the novel relative ...... self-administration in rats".
@en
P2093
Eduardo R Butelman
P2860
P2888
P304
P356
10.1007/S00213-017-4647-0
P577
2017-05-27T00:00:00Z